Structures by: Abdel-Aziz A. A.
Total: 27
6-Methyl-3-phenyl-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-4-one
C15H12N2OS
Acta Crystallographica Section E (2012) 68, 3 o862
a=12.7770(3)Å b=5.13840(10)Å c=19.0973(4)Å
α=90.00° β=91.814(2)° γ=90.00°
4-Oxo-2,4-diphenylbutanenitrile
C16H13NO
Acta Crystallographica Section E (2012) 68, 3 o736
a=14.2158(3)Å b=8.9244(2)Å c=9.7553(2)Å
α=90.00° β=99.217(2)° γ=90.00°
2-(4-Methoxyphenyl)-4-oxo-4-phenylbutanenitrile
C17H15NO2
Acta Crystallographica Section E (2012) 68, 3 o737
a=9.5730(2)Å b=8.7748(2)Å c=32.0620(7)Å
α=90.00° β=90.00° γ=90.00°
Methyl 3-[(6-nitro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)sulfanyl]propanoate
C18H15N3O5S
Acta Crystallographica Section E (2013) 69, 7 o1111
a=4.9146(3)Å b=26.5065(18)Å c=14.0900(9)Å
α=90.00° β=94.645(4)° γ=90.00°
3-[2-(4-Fluorophenyl)-2-oxoethyl]-5,5-diphenylimidazolidine-2,4-dione
C23H17FN2O3
Acta Crystallographica Section E (2014) 70, 2 o226-o227
a=19.9622(16)Å b=8.0484(6)Å c=22.8969(18)Å
α=90.00° β=90.00° γ=90.00°
2-Methyl-3-(2-methylphenyl)-4-oxo-3,4-dihydroquinazolin-8-yl benzoate
C23H18N2O3
Acta Crystallographica Section E (2012) 68, 3 o732-o733
a=20.3847(4)Å b=7.43520(10)Å c=12.7829(3)Å
α=90.00° β=107.489(2)° γ=90.00°
2-Methyl-3-(2-methylphenyl)-4-oxo-3,4-dihydroquinazolin-8-yl 4-bromobenzene-1-sulfonate
C22H17BrN2O4S
Acta Crystallographica Section E (2012) 68, 3 o759-o760
a=11.0587(3)Å b=14.4794(3)Å c=13.1357(3)Å
α=90.00° β=102.804(2)° γ=90.00°
2-Methyl-3-(2-methylphenyl)-4-oxo-3,4-dihydroquinazolin-8-yl 4-methylbenzoate
C24H20N2O3
Acta Crystallographica Section E (2012) 68, 3 o734-o735
a=18.8216(5)Å b=7.6332(2)Å c=13.3092(3)Å
α=90.00° β=97.286(2)° γ=90.00°
2-Methyl-3-(2-methylphenyl)-4-oxo-3,4-dihydroquinazolin-8-yl thiophene-2-carboxylate
C21H16N2O3S
Acta Crystallographica Section E (2012) 68, 3 o756-o757
a=5.80310(10)Å b=13.4281(2)Å c=22.4853(4)Å
α=90.00° β=93.115(2)° γ=90.00°
2-Methyl-3-(2-methylphenyl)-7-nitroquinazolin-4(3<i>H</i>)-one
C16H13N3O3
Acta Crystallographica Section E (2012) 68, 3 o863
a=14.4614(5)Å b=16.5383(4)Å c=12.9968(4)Å
α=90.00° β=119.072(4)° γ=90.00°
8-Benzyloxy-2-methyl-3-(2-methylphenyl)quinazolin-4(3<i>H</i>)-one
C23H20N2O2
Acta Crystallographica Section E (2012) 68, 3 o864-o865
a=18.2611(3)Å b=7.62660(10)Å c=13.2148(2)Å
α=90.00° β=91.094(2)° γ=90.00°
2-Methylsulfanyl-9<i>H</i>-1,3,4-thiadiazolo[2,3-<i>b</i>]quinazolin-9-one
C10H7N3OS2
Acta Crystallographica Section E (2012) 68, 7 o2134
a=11.8193(4)Å b=4.9841(2)Å c=17.4985(6)Å
α=90.00° β=91.453(3)° γ=90.00°
2-Methyl-3-(2-methylphenyl)-4-oxo-3,4-dihydroquinazolin-8-yl 4-chlorobenzoate
C23H17ClN2O3
Acta Crystallographica Section E (2012) 68, 7 o2052-o2053
a=18.6703(5)Å b=7.6203(2)Å c=13.3756(3)Å
α=90.00° β=98.006(3)° γ=90.00°
2-Methoxy-4,6-diphenylnicotinonitrile
C19H14N2O
Acta Crystallographica Section E (2014) 70, 2 o228
a=15.0686(16)Å b=24.327(3)Å c=3.8986(4)Å
α=90.00° β=90.00° γ=90.00°
1-Acetyl-5-methoxy-4-(phenylsulfanyl)imidazolidin-2-one
C12H14N2O3S
Acta Crystallographica Section E (2014) 70, 2 o145-o146
a=9.0371(8)Å b=12.0642(10)Å c=12.8369(11)Å
α=93.0660(10)° β=105.8690(10)° γ=111.5740(10)°
<i>N</i>-(3-Aminobicyclo[2.2.1]heptan-2-yl)-4-methylbenzenesulfonamide
C14H20N2O2S
Acta Crystallographica Section E (2012) 68, 7 o2032
a=10.1715(2)Å b=6.11690(10)Å c=11.5150(3)Å
α=90.00° β=110.332(2)° γ=90.00°
(11<i>R</i>,12<i>S</i>)-16-Aminotetracyclo[6.6.2.0^2,7^.0^9,14^]hexadeca- 2(7),3,5,9(14),10,12-hexaen-15-ol
C16H15NO
Acta Crystallographica Section E (2012) 68, 7 o2137
a=8.6224(2)Å b=7.11400(10)Å c=10.0210(2)Å
α=90.00° β=106.707(2)° γ=90.00°
5-Isopropylimidazolidine-2,4-dione monohydrate
C6H10N2O2,H2O
Acta Crystallographica Section E (2012) 68, 2 o533
a=6.2688(3)Å b=9.2387(4)Å c=14.8280(7)Å
α=90.00° β=90.00° γ=90.00°
2,6-Bis[(<i>S</i>)-1-phenylethyl]-1<i>H</i>,5<i>H</i>- pyrrolo[3,4-<i>f</i>]isoindole-1,3,5,7(2<i>H</i>,6<i>H</i>)-tetrone
C26H20N2O4
Acta Crystallographica Section E (2012) 68, 3 o907
a=5.64010(10)Å b=16.1040(2)Å c=11.3759(2)Å
α=90.00° β=99.762(2)° γ=90.00°
1-Acetyl-4-(phenylsulfanyl)imidazolidin-2-one
C11H12N2O2S
Acta Crystallographica Section E (2012) 68, 3 o908
a=7.04730(10)Å b=14.3274(3)Å c=10.7796(2)Å
α=90.00° β=96.921(2)° γ=90.00°
<i>S</i>-Phenyl 4-methoxybenzothioate
C14H12O2S
Acta Crystallographica Section E (2012) 68, 4 o1074-o1075
a=5.4478(2)Å b=8.2149(3)Å c=27.3841(6)Å
α=90.00° β=90.00° γ=90.00°
2-(2-{[4-Oxo-3-(2-phenylethyl)-3,4-dihydroquinazolin-2-yl]sulfanyl}ethyl)-2,3- dihydro-1<i>H</i>-isoindole-1,3-dione
C26H21N3O3S
Acta Crystallographica Section E (2012) 68, 7 o2057-o2058
a=8.7346(4)Å b=9.4464(6)Å c=13.7373(8)Å
α=94.258(5)° β=103.505(5)° γ=105.227(5)°
(Adamantan-1-yl)(phenylsulfanyl)methanone
C17H20OS
Acta Crystallographica Section E (2012) 68, 7 o2104
a=6.35450(10)Å b=39.4559(5)Å c=11.38780(10)Å
α=90.00° β=99.8790(10)° γ=90.00°
2-{[2-Methyl-3-(2-methylphenyl)-4-oxo-3,4-dihydroquinazolin-8- yl]oxy}acetonitrile
C18H15N3O2
Acta Crystallographica Section E (2012) 68, 7 o2105-o2106
a=15.4721(3)Å b=6.77750(10)Å c=15.0124(4)Å
α=90.00° β=109.143(3)° γ=90.00°
3-Amino-5,5-diphenylimidazolidine-2,4-dione
C15H13N3O2
Acta Crystallographica Section E (2014) 70, 3 o262-o263
a=20.1565(7)Å b=6.1651(2)Å c=20.3250(7)Å
α=90° β=97.781(2)° γ=90°
4-[(1,3-Dioxoisoindolin-2-yl)methyl]benzenesulfonamide
C15H12N2O4S
Acta Crystallographica Section E (2014) 70, 3 o291-o292
a=4.98030(10)Å b=26.5291(7)Å c=10.2740(3)Å
α=90° β=90.8040(10)° γ=90°
<i>N</i>-(12-Amino-9,10-dihydro-9,10-ethanoanthracen-11-yl)-4-\ methylbenzenesulfonamide
C23H22N2O2S
Acta Crystallographica Section E (2014) 70, 3 o248-o249
a=8.9362(2)Å b=6.8766(2)Å c=15.5039(4)Å
α=90° β=91.5400(10)° γ=90°